Literature DB >> 7564231

Biochemical follow-up in late-treated nephropathic cystinosis.

M A Vilaseca1, J A Camacho, P Briones, C Farré, A Mas.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7564231     DOI： 10.1007/BF00711751

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN： 0141-8955            Impact factor:   4.982


× No keyword cloud information.
  9 in total

1.  Treatment of cystinosis with cysteamine from early infancy.

Authors:  V M Reznik; M Adamson; R D Adelman; J L Murphy; W A Gahl; K F Clark; J A Schneider
Journal:  J Pediatr       Date:  1991-09       Impact factor: 4.406

Review 2.  Cystinosis.

Authors:  M D Adamson; H C Andersson; W A Gahl
Journal:  Semin Nephrol       Date:  1989-06       Impact factor: 5.299

3.  Predicted reciprocal serum creatinine at age 10 years as a measure of renal function in children with nephropathic cystinosis treated with oral cysteamine.

Authors:  W A Gahl; J A Schneider; J D Schulman; J G Thoene; G F Reed
Journal:  Pediatr Nephrol       Date:  1990-03       Impact factor: 3.714

Review 4.  Update on nephropathic cystinosis.

Authors:  J A Schneider; B Katz; R B Melles
Journal:  Pediatr Nephrol       Date:  1990-11       Impact factor: 3.714

5.  Cysteamine therapy for children with nephropathic cystinosis.

Authors:  W A Gahl; G F Reed; J G Thoene; J D Schulman; W B Rizzo; A J Jonas; D W Denman; J J Schlesselman; B J Corden; J A Schneider
Journal:  N Engl J Med       Date:  1987-04-16       Impact factor: 91.245

6.  Muscle carnitine repletion by long-term carnitine supplementation in nephropathic cystinosis.

Authors:  W A Gahl; I M Bernardini; M C Dalakas; T C Markello; D M Krasnewich; L R Charnas
Journal:  Pediatr Res       Date:  1993-08       Impact factor: 3.756

7.  An X-linked mitochondrial disease affecting cardiac muscle, skeletal muscle and neutrophil leucocytes.

Authors:  P G Barth; H R Scholte; J A Berden; J M Van der Klei-Van Moorsel; I E Luyt-Houwen; E T Van 't Veer-Korthof; J J Van der Harten; M A Sobotka-Plojhar
Journal:  J Neurol Sci       Date:  1983-12       Impact factor: 3.181

8.  Parenchymal organ cystine depletion with long-term cysteamine therapy.

Authors:  W A Gahl; L Charnas; T C Markello; I Bernardini; K G Ishak; M C Dalakas
Journal:  Biochem Med Metab Biol       Date:  1992-12

9.  Improved renal function in children with cystinosis treated with cysteamine.

Authors:  T C Markello; I M Bernardini; W A Gahl
Journal:  N Engl J Med       Date:  1993-04-22       Impact factor: 91.245
  9 in total
  3 in total

Review 1.  Nephropathic cystinosis: late complications of a multisystemic disease.

Authors:  Galina Nesterova; William Gahl
Journal:  Pediatr Nephrol       Date:  2008-06       Impact factor: 3.714

2.  Association of proportion of the HDL-cholesterol subclasses HDL-2b and HDL-3 and macrovascular events among patients undergoing hemodialysis.

Authors:  Wen-Chin Lee; Jin-Bor Chen; Sin-Hua Moi; Cheng-Hong Yang
Journal:  Sci Rep       Date:  2021-01-21       Impact factor: 4.379

Review 3.  Cystinosis: the evolution of a treatable disease.

Authors:  Galina Nesterova; William A Gahl
Journal:  Pediatr Nephrol       Date:  2012-08-18       Impact factor: 3.714
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.